| Eric Krasnoff, Pall CEO, stated, “Life Sciences continues to perform well with sales growing over 7% in Q1. BioPharmaceuticals grew 10% and was particularly strong in the Western Hemisphere. Many of the industrial end markets Pall serves continue to be depressed. Pall sales to these markets are down 15.5% compared to a year ago.” :theflyonthewall.com |
